MD2231B1 - Composition for treatment of oncologic pathologies - Google Patents

Composition for treatment of oncologic pathologies

Info

Publication number
MD2231B1
MD2231B1 MD20030069A MD20030069A MD2231B1 MD 2231 B1 MD2231 B1 MD 2231B1 MD 20030069 A MD20030069 A MD 20030069A MD 20030069 A MD20030069 A MD 20030069A MD 2231 B1 MD2231 B1 MD 2231B1
Authority
MD
Moldova
Prior art keywords
oil
treatment
composition
amaranthine
oncologic
Prior art date
Application number
MD20030069A
Other languages
Romanian (ro)
Other versions
MD2231C2 (en
Inventor
Ion Calmic
Original Assignee
Ion Calmic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ion Calmic filed Critical Ion Calmic
Priority to MDA20030069A priority Critical patent/MD2231C2/en
Publication of MD2231B1 publication Critical patent/MD2231B1/en
Publication of MD2231C2 publication Critical patent/MD2231C2/en

Links

Landscapes

  • Edible Oils And Fats (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to medicine, in particular to oncology. Summary of the invention consists in that it is proposed a composition containing amaranthine oil and vegetable oil, which additionally contains 58...62% of ethyl alcohol, and in the capacity of vegetable oil is used refined sunflower oil, in the following ratio, % vol.:amaranthine oil 12...15refined sunflower oil 42...45ethyl alcohopl 42...45.Claims: 1
MDA20030069A 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies MD2231C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Publications (2)

Publication Number Publication Date
MD2231B1 true MD2231B1 (en) 2003-08-31
MD2231C2 MD2231C2 (en) 2004-02-29

Family

ID=29268042

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Country Status (1)

Country Link
MD (1) MD2231C2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067451C1 (en) * 1993-01-22 1996-10-10 Научно-исследовательский институт фармакологии Томского научного центра РАМН Method of preparing agent showing antitumor action
KR100205045B1 (en) * 1996-12-05 1999-06-15 김송배 Novel triterpene glycosidic compound process thereof
KR100312622B1 (en) * 1998-11-03 2002-02-28 김송배 Stabilized anticancer composition mainly composed of herbal medicine and its manufacturing method
US20030017215A1 (en) * 1998-12-07 2003-01-23 Steven M. Bessette Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
RU2201246C2 (en) * 2001-02-28 2003-03-27 Малеева Галина Лаврентьевна Agent for treatment of oncological patient in postoperative period
RU2204405C1 (en) * 2002-01-28 2003-05-20 Берников Владимир Яковлевич Agent eliciting adaptogenic activity

Also Published As

Publication number Publication date
MD2231C2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
SG155189A1 (en) Novel fenofibrate formulations and related methods of treatment
TW200513193A (en) Fat or oil composition
ATE292460T1 (en) COMPOSITIONS CONTAINING ACTIVE STILBENOID COMPOUNDS FOR LOWERING TRIGLYCERIDE LEVELS
MX2007005486A (en) High pufa oil compositions.
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
MXPA05013824A (en) 5-membered heterocycle-based p38 kinase inhibitors.
PT1635824E (en) 5-membered heterocycle-based p-38 inhibitors
AP2002002426A0 (en) Ppar agonists
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
HK1081959A1 (en) Thienopyriminediones and their use in the modulation of autoimmune disease
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
TW200420288A (en) Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
UA91676C2 (en) Composition comprising a jnk inhibitor and cyclosporin
WO2004041269A3 (en) New use for pharmaceutical composition
MX2009008290A (en) Antiperspirant / deodorant compositions.
TW200724140A (en) Hydantoin compounds
MX2008001597A (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment.
IL153147A0 (en) Phospholipid derivatives of valporic acid and mixtures thereof
MY154783A (en) Oral care composition containing a mixed tocopherol component
EE05357B1 (en) A tablet containing at least two distinct segments and its use
WO2004052294A3 (en) Compositions and methods related to lipid:emodin formulations
MD2231B1 (en) Composition for treatment of oncologic pathologies
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
MD1650G2 (en) 3,5-Dibromsalicylidenethiosemicarbazidopyridinecopper possessing antistaphylococcia and antistreptococcia activity

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees